Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person OLIG2, whose expression is highly tissue-specific, seems to ...
| Class:Id | Summation:9942016 |
|---|
| _displayName | OLIG2, whose expression is highly tissue-specific, seems to ... |
|---|
| _timestamp | 2026-04-01 04:31:37 |
|---|
| created | [InstanceEdit:9942010] Orlic-Milacic, Marija, 2025-03-13 |
|---|
| literatureReference | [LiteratureReference:9942012] Olig2 and Ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells
[LiteratureReference:9973083] Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179 |
|---|
| modified | [InstanceEdit:9973098] Orlic-Milacic, Marija, 2025-11-14
[InstanceEdit:9986409] Orlic-Milacic, Marija, 2026-04-01 |
|---|
| text | OLIG2, whose expression is highly tissue-specific, seems to favor homodimerization over heterodimerization with class A bHLH transcription factors (Lee et al. 2005). An inhibtor of OLIG2 homodimerization, CT-179, prolongs survival in the Sonic Hedgehog group of medulloblastoma organoid-based models (Li et al. 2025). |
|---|
| (summation) | [Reaction:9942014] OLIG2 homodimerizes [Homo sapiens] |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by OLIG2, whose expression is highly tissue-specific, seems to ... (9942016)
